The therapy for urogenital tuberculosis
Küçük Resim Yok
Tarih
2023
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Marmara Univ, Fac Medicine
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Tuberculosis (TB) is a communicable disease that is a major cause of ill health. Urogenital TB was a frequent urological disease in the pre-antibiotic era: about 20% of patients in urological hospitals had renal TB, mostly in the form of pyonephrosis. We composed a narrative review of the literature with keywords urogenital tuberculosis', prostate tuberculosis kidney tuberculosis, treatment of tuberculosis.Urogenital TB (UGTB) includes TB of the kidney and the urinary tract and male and female genital TB. Each clinical presentation requires tailored antibiotic therapy depending on stage and general management. Anti-TB therapy should be multicomponent, continuous, long-lasting and controlled with a follow-up for 2-3 years. Otherwise, the risks of development of drug-resistance and relapse increase.Index of suspicion on UGTB is generally low, causing a delay in diagnosis; consequently, complicated forms of UGTB respond poorly to anti-TB therapy, while timely diagnosed minor forms are curable medically without surgery. Even with timely diagnosed UGTB, non-optimal therapy may result in over-fibrosis, scarring and strictures of the urinary tract, making surgical repair inevitable. Nevertheless, we have a wide enough spectrum of anti-TB drugs to cure urogenital TB.
Açıklama
Anahtar Kelimeler
Urogenital Tuberculosis, Prostate Tuberculosis, Kidney Tuberculosis, Treatment, Drug-Resistant Tuberculosis, Bladder-Cancer, Glans-Penis, Series
Kaynak
Marmara Medical Journal
WoS Q Değeri
N/A
Scopus Q Değeri
Q4
Cilt
36
Sayı
3
